Detection of immunoregulatory rheumatoid factor
- Authors: Beduleva L.М.1, Sidorov A.Y.1, Abisheva N.N.1, Gilmanova L.U.1, Gorbushina A.N.1
-
Affiliations:
- Udmurt State University
- Issue: Vol 23, No 2 (2020)
- Pages: 187-190
- Section: SHORT COMMUNICATIONS
- Submitted: 20.10.2020
- Accepted: 20.10.2020
- Published: 15.04.2020
- URL: https://rusimmun.ru/jour/article/view/564
- DOI: https://doi.org/10.46235/1028-7221-267-DOI
- ID: 564
Cite item
Full Text
Abstract
Regulatory rheumatoid factor (regRF) represents a separate rheumatoid factor population that might be potentially used for clinical diagnostics, whereas regRF-producing lymphocytes serve as a promising therapeutic target for autoimmune diseases. Hence, it is worth outlining conditions allowing to reliably detect regRF in humans and laboratory animals. The method of agglutination with tanned IgG-loaded red blood cells was used to measure level of regulatory rheumatoid factor, because it allows to identify solely regRF as compared to the latex fixation method detecting both the regulatory rheumatoid factor as well as the rheumatoid factor associated with rheumatic diseases. It was found that fresh or frozen serum should be used to detect regRF in rats. Freshly purified rat blood plasma stabilized with heparin, sodium citrate or EDTA did not allow to detect regRF, potentially being linked to the presence of fibrinogen known to demonstrate IgG binding activity. In addition, heparin itself also complicates regRF detection in rats. In humans, regRF was reliably detected in pre-frozen plasma stabilized with sodium citrate. Finally, false-negative results were obtained in a small number of cases while using blood serum for detecting regRF in humans.
About the authors
L. М. Beduleva
Udmurt State University
Author for correspondence.
Email: blv76@mail.ru
Beduleva Lyubov V. - PhD, MD (Biology), Head, Laboratory of Molecular and Cell Immunology
426034, Udmurt Republic, Izhevsk, Universitetskaya str., 1
Phone: 7 (3412) 91-64-26
Russian FederationA. Yu. Sidorov
Udmurt State University
Email: fake@neicon.ru
Research Associate, Laboratory of Molecular and Cell Immunology
Izhevsk, Udmurt Republic
Russian FederationN. N. Abisheva
Udmurt State University
Email: fake@neicon.ru
Research Associate, Laboratory of Molecular and Cell Immunology
Izhevsk, Udmurt Republic
Russian FederationL. U. Gilmanova
Udmurt State University
Email: fake@neicon.ru
Junior Research Associate, Laboratory of Molecular and Cell Immunology
Izhevsk, Udmurt Republic
Russian FederationA. N. Gorbushina
Udmurt State University
Email: fake@neicon.ru
Junior Research Associate, Laboratory of Molecular and Cell Immunology
Izhevsk, Udmurt Republic
Russian FederationReferences
- Beduleva L., Menshikov I., Stolyarova E., Fomina K., Lobanova O., Ivanov P. Terentiev A. Rheumatoid factor in idiotypic regulation of autoimmunity. Int. J. Rheum. Dis., 2015, Vol. 18, pp. 408-420.
- Boehm T.K., DeNardin E. Fibrinogen binds IgG antibody and enhances IgG-mediated phagocytosis. Hum. Antibodies, 2008, Vol. 17, no. 3-4, pp. 45-56.
- Fong S., Chen P.P., Crowley J.J., Silverman G.J., Carson D.A. Idiotypes and the structural diversity of human rheumatoid factors. Springer Semin. Immunopathol., 1988, Vol. 10, pp. 189-201.
- Mageed R.A., Moyes S.P., Thompson K.M., Natvig J.B. Molecular and сellular aspects of human rheumatoid factor production and idiotypes. In: Shoenfeld Y., Kennedy R.C., Ferrone S. (ed) Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Elsevier, 1997, pp. 135-155.
- Monestier M., Bellon B., Manheimer A.J., Bona C.A. Rheumatoid factors. Immunochemical, molecular, and regulatory properties. Ann. N. Y. Acad. Sci., 1986, Vol. 475, pp. 106-113.
- Sidorov A., Beduleva L., Menshikov I., Terentiev A., Stolyarova E., Abisheva N. Fc fragments of immunoglobulin G are an inductor of regulatory rheumatoid factor and a promising therapeutic agent for rheumatic diseases. Int. J. Biol. Macromol., 2017, Vol. 95, pp. 938-945.
- Sidorov A., Beduleva L., Menshikov I., Terentiev A., Cherepanov I. Physicochemical characteristics of human IgG Fc fragments that expose regulatory rheumatoid factor neoepitopes and may show promise as antirheumatic agents. Biotechnol. Appl. Biochem., 2019, Vol. 67, no. 2, pp. 287-293.
- Stolyarova E., Beduleva L., Menshikov I., Snigiryev A., Khramova T. Mechanism by which regulatory rheumatoid factor prevents experimental autoimmune encephalomyelitis. Endocr. Metab. Immune Disord. Drug Targets, 2018, Vol. 18, pp. 596-601.